Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
James G. Marken
7 Jun 2024
SVP Ops & Prod Dev
Exercised, kept
5,300
$57.06
$302.42K
James G. Marken
7 Jun 2024
SVP Ops & Prod Dev
Exercised, kept
7,250
$49.51
$358.95K
Robert E. Brown JR
16 May 2019
Director
Exercised, kept
1,167
$33.00
$38.51K
Robert E. Brown JR
16 May 2019
Director
Exercised, kept
1,042
$6.36
$6.63K
Robert W Schrepfer
11 Sep 2018
SVP - New Bus Dev & Spec Sales
Exercised, kept
28,688
$6.60
$189.34K
Showing 250 of 268 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 443
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 127
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 29 Sep 2006